This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Choosing zero based budgeting can significantly improve your financial awareness. Discover the reasons to adopt this method today.
22,496 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
The AI hype cycle has investors chasing the next breakout. This article identifies a stock I would avoid and a choice...
Two of the most talked-about leveraged ETFs are the ProShares SSO and the UltraPro TQQQ. This guide explains how they...
A routine ethics filing has become a focal point for investors and policymakers. This deep dive explains what the qua...
Micron's stock jumped more than 600% in a year, sparking a lively debate about a possible stock split. This guide bre...
Investors wonder if AMD can reach a trillion-dollar milestone in the fast-changing chip landscape. This article break...
In May, sweetgreen stock jumped 45% as the company signaled a path to recovery. This article breaks down the catalyst...
NASA is laying out a bold path to a sustained lunar presence. This guide explains how NASA plans Moon. here translate...
After a rough stretch for tech shares, Micron stock bounced back, signaling a renewed interest in memory makers. This...
A fresh AMD collaboration sparked a sharp move in Rackspace shares. This article breaks down what happened, why it ma...
A Minneapolis-area father and son are under indictment for allegedly filing false tax refunds using a questionable se...
A major enforcement push in Louisiana led to 21 new arrests in a Medicaid fraud crackdown. This article explains what...